Disc Medicine Inc（IRON）财务数据IRONDisc Medicine Inc

Evaluating the bottom line, Disc Medicine, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -39.08%, provide a clear picture of how effectively IRON converts its operational activities into shareholder value.

In the context of the broader market, IRON competes directly with industry leaders such as AUPH and CLDX. With a market capitalization of $3.03B, it holds a leading position in the sector. When comparing efficiency, IRON's gross margin of N/A stands against AUPH's 92.12% and CLDX's 100.00%. Such benchmarking helps identify whether Disc Medicine, Inc. is trading at a premium or discount relative to its financial performance.

Disc Medicine has reported significant losses, with net income reaching -$63,504,000 in Q1 2026 and an EPS of -1.65. The company has a current ratio of 24.14, indicating strong liquidity, but the overall financial performance is concerning due to persistent losses.